Phase 1 open-label, fixed sequence study to determine the effect of OATP1B1/1B3 inhibition (cyclosporin A, CsA) and CYP3A4 induction (carbamazepine, CBZ) on the pharmacokinetics (PK) of Remdesivir
Latest Information Update: 09 Feb 2024
At a glance
- Drugs Remdesivir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 09 Feb 2024 New trial record